Report Detail

Pharmaceuticals & Healthcare HanAll Biopharma Co Ltd (009420) - Financial and Strategic SWOT Analysis Review

  • RnM1038501
  • |
  • 14 June, 2019
  • |
  • Global
  • |
  • 25 pages
  • |
  • GlobalData
  • |
  • Pharmaceuticals & Healthcare

HanAll Biopharma Co Ltd (009420) - Financial and Strategic SWOT Analysis Review

Table of Contents

    Section 1 - About the Company

      HanAll Biopharma Co Ltd - Key Information

        HanAll Biopharma Co Ltd - Overview

          HanAll Biopharma Co Ltd - Key Employees

            HanAll Biopharma Co Ltd - Key Employee Biographies

              HanAll Biopharma Co Ltd - Key Operational Heads

                HanAll Biopharma Co Ltd - Major Products and Services

                  HanAll Biopharma Co Ltd - History

                    HanAll Biopharma Co Ltd - Company Statement

                      HanAll Biopharma Co Ltd - Locations And Subsidiaries

                        HanAll Biopharma Co Ltd - Key Manufacturing facilities

                          Head Office

                            Other Locations & Subsidiaries

                              Section 2 - Company Analysis

                                HanAll Biopharma Co Ltd - Business Description

                                  HanAll Biopharma Co Ltd - Corporate Strategy

                                    HanAll Biopharma Co Ltd - SWOT Analysis

                                      SWOT Analysis - Overview

                                        HanAll Biopharma Co Ltd - Strengths

                                          HanAll Biopharma Co Ltd - Weaknesses

                                            HanAll Biopharma Co Ltd - Opportunities

                                              HanAll Biopharma Co Ltd - Threats

                                                HanAll Biopharma Co Ltd - Key Competitors

                                                  Section 3 - Company Financial Performance Charts

                                                    HanAll Biopharma Co Ltd - Financial Ratios

                                                      Financial Ratios - Capital Market Ratios

                                                        Financial Ratios - Annual Ratios

                                                          Financial Ratios - Interim Ratios

                                                            Financial Ratios - Ratio Charts

                                                              Section 4 - Appendix

                                                                Appendix

                                                                  Methodology

                                                                    Ratio Definitions

                                                                      About GlobalData

                                                                        Contact Us

                                                                          Disclaimer

                                                                            Note*: Some sections may be missing if data is unavailable for the company

                                                                            Summary

                                                                            HanAll Biopharma Co Ltd (HanAll), formerly HanAll Pharmaceutical Co Ltd, is a pharmaceutical company that offers drug delivery, biotherapeutics, and small molecule discovery programs. The company develops drugs in therapeutic areas of ophthalmology, immunology, cardiovascular disease, dermatology and biobetter. It offers drug research and development, medical information and advanced products. HanAll operates through its research and development center and biotechnology research institute. The company’s products are used in treatment of autoimmune diseases, dry eye diseases, and recurrent and intractable cancer. It has operations in South Korea and the US. HanAll is headquartered in Seoul, South Korea.

                                                                            HanAll Biopharma Co Ltd Key Recent Developments

                                                                            Feb 25,2019: US patent office awards GLUCODOWN trademark for expanded distribution of new diabetic tea flavors

                                                                            This comprehensive SWOT profile of HanAll Biopharma Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

                                                                            This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of HanAll Biopharma Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

                                                                            The profile contains critical company information including*,

                                                                            - Business description – A detailed description of the company’s operations and business divisions.
                                                                            - Corporate strategy – Analyst’s summarization of the company’s business strategy.
                                                                            - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
                                                                            - Company history – Progression of key events associated with the company.
                                                                            - Major products and services – A list of major products, services and brands of the company.
                                                                            - Key competitors – A list of key competitors to the company.
                                                                            - Key employees – A list of the key executives of the company.
                                                                            - Executive biographies – A brief summary of the executives’ employment history.
                                                                            - Key operational heads – A list of personnel heading key departments/functions.
                                                                            - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
                                                                            - Key manufacturing facilities – A list of key manufacturing facilities of the company.
                                                                            - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
                                                                            - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

                                                                            Note*: Some sections may be missing if data is unavailable for the company.

                                                                            Key benefits of buying this profile include,

                                                                            You get detailed information about the company and its operations to identify potential customers and suppliers.
                                                                            - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

                                                                            Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
                                                                            - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

                                                                            Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
                                                                            - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

                                                                            Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
                                                                            - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

                                                                            Gain key insights into the company for academic or business research.
                                                                            - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



                                                                            REPORT YOU MIGHT BE INTERESTED

                                                                            Purchase this Report

                                                                            $300.00
                                                                            $600.00
                                                                            $900.00
                                                                            238.27
                                                                            476.53
                                                                            714.80
                                                                            267.68
                                                                            535.36
                                                                            803.03
                                                                            32,504.40
                                                                            65,008.80
                                                                            97,513.20
                                                                            20,903.55
                                                                            41,807.10
                                                                            62,710.65
                                                                            Credit card Logo

                                                                            Related Reports


                                                                            Reason to Buy

                                                                            Request for Sample of this report